iZafe Group

iZafe Group EBIT per Employee

The EBIT per Employee of iZafe Group (IZAFE B.ST) as of Nov 19, 2026 is -1.67 M SEK. In the previous year, EBIT per Employee was -1.77 M SEK — a change of -5.33% (higher).

EBIT per Employee

-1.67 MSEK

YoY

-5.33%

Last updated:

EBIT per Employee of iZafe Group is 2025 -1.67 M SEK. EBIT per Employee of iZafe Group was 2024 -1.77 M SEK. It decreases by -5.33% higher compared to the previous year.

The iZafe Group EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2018
-976,272.73 SEK
Jan 1, 2019
-2.05 M SEK
Jan 1, 2020
-1.10 M SEK
Jan 1, 2021
-3.02 M SEK
Jan 1, 2022
-2.13 M SEK
Jan 1, 2023
-3.23 M SEK
Jan 1, 2024
-1.77 M SEK
Jan 1, 2025
-1.67 M SEK
The iZafe Group EBIT per Employee history
YEAREBIT per EmployeeYoY
-1.67 MSEK-5.33%
-1.77 MSEK-45.24%
-3.23 MSEK+51.58%
-2.13 MSEK-29.66%
-3.02 MSEK+174.71%
-1.10 MSEK-46.39%
-2.05 MSEK+110.38%
-976,272.73SEK+153.40%
-385,272.73SEK-34.48%
-588,026.00SEK+120.94%
-266,150.73SEK-16.61%
-319,176.09SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

iZafe Group Stock analysis

What does iZafe Group do? iZafe Group AB develops medical and digital security solutions, including Dosell, a patented drug dispenser for home medication with remote monitoring, and MediKoll, an app providing medication side effect and allergy information. The company serves pharmaceutical companies, hospitals, care homes, and pharmacies in the global market. Its products target patients and healthcare providers seeking secure, remote medication management and personalized health information. Dosell is under development as a home medication solution, while MediKoll offers real-time data on medication reactions. The firm's revenue comes from selling these digital tools to healthcare institutions and pharmaceutical partners, focusing on improving patient safety and reducing medication errors through technology. iZafe Group AB's business model relies on the global healthcare sector's demand for innovative digital tools. The company's offerings are tailored for pharmaceutical firms, hospitals, care homes, and pharmacies, leveraging remote monitoring capabilities to address medication management challenges in home and clinical settings. iZafe Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about iZafe Group stock

EBIT per Employee of iZafe Group is -1.67 M SEK in 2025.

EBIT per Employee of iZafe Group changed from -1.77 M SEK to -1.67 M SEK, representing a -5.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee iZafe Group since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's iZafe Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — iZafe Group

All Key Metrics — iZafe Group